PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New guideline for Helicobacter pylori includes change to primary treatment recommendation

2024-09-04
(Press-News.org) The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) infection.

The corresponding author on the guideline is William D. Chey, M.D., chief of the Division of Gastroenterology and Hepatology at Michigan.

H. pylori is a bacterium that infects over half the people in the world, though most are asymptomatic.

It can cause dyspepsia, peptic ulcer disease and gastric cancer. 

This latest clinical practice guideline notes that its prevalence in North America is decreasing, but it still infects 30-40% of the population.

A previous guideline was published in 2017. It had maintained the recommendation of a proton pump inhibitor-clarithromycin triple therapy as the primary treatment option.

In the new guideline, the number one recommendation for treatment-naïve patients is bismuth quadruple therapy. 

That treatment typically includes a PPI, tetracycline, bismuth and a nitroimidazole for 14 days. 

“We were already recommending that healthcare providers move away from PPI triple therapy in 2017 because of increasing problems with chloromycetin resistance amongst H. pylori strains in the United States,” Chey said. 

“Despite that recommendation, PPI triple therapy still dominates first-line therapy prescriptions for H. pylori patients in the United States. In this newest iteration of the guideline, we are very clear to say that in essentially all circumstances you should not be prescribing PPI triple therapy, and you should be instead using bismuth quadruple therapy or one of the other suggested treatment options.”

The guideline makes 12 total treatment suggestions for patients in a variety of different situations.  

The number two recommendation for treatment-naïve patients—after bismuth quadruple therapy—is rifabutin triple therapy (a PPI, rifabutin and amoxicillin.)

A third option consists of a new, highly potent drug which blocks stomach acid production called vonoprazan combined with the antibiotic amoxicillin.

Besides the move away from PPI triple therapy, another change from the 2017 guideline is the discussion of increasingly available molecular testing for antibiotic susceptibility. 

“Molecular testing really opens the door to the possibility of more liberally utilizing antibiotic sensitivity testing as a mechanism of tailoring therapy to the antibiotics that H. pylori or a person infected with H. pylori is sensitive to,” Chey said. 

The guideline also outlines future research priorities, such as identifying which individuals would most benefit from H. pylori testing to prevent gastric cancer and evaluating newly FDA-approved regimens for persistent infections.

Additional authors: Colin W. Howden, M.D., Steven F. Moss, M.D., Douglas R. Morgan, M.D., M.P.H., Katarina B. Greer, M.D., M.S., Shilpa Grover, M.D., M.P.H., Shailja C. Shah, M.D., M.P.H.

END


ELSE PRESS RELEASES FROM THIS DATE:

Making desalination more efficient, by way of renewable energy

2024-09-04
(Santa Barbara, Calif.) — With freshwater becoming an ever scarcer resource, desalination of ocean water is increasingly employed to bridge the gap between supply and demand. However, desalination is energy-intensive, often powered by fossil fuels, so meeting the need for freshwater can exacerbate the challenge of reducing atmospheric CO2, the main driver of climate change. Yangying Zhu, an assistant professor in the Department of Mechanical Engineering at UC Santa Barbara, wants to address that conundrum. Now, a two-year, $500,000 seed grant from the Advanced Research Projects Agency-Energy (ARPA-E) ...

Preventing car battery fires with help from machine learning

Preventing car battery fires with help from machine learning
2024-09-04
One of the most critical safety concerns for electric vehicles is keeping their batteries cool, as temperature spikes can lead to dangerous consequences. New research led by a University of Arizona doctoral student proposes a way to predict and prevent temperature spikes in the lithium-ion batteries commonly used to power such vehicles.  The paper "Advancing Battery Safety," led by College of Engineering doctoral student Basab Goswami, is published in the Journal of Power Sources.  With the support of $599,808 from the Department of Defense's Defense Established Program to Stimulate Competitive Research, Goswami and his adviser, aerospace ...

Heavy metal cadmium may be tied to memory issues for some

2024-09-04
MINNEAPOLIS – The heavy metal cadmium, which is found in the air, water, food and soil, is known to cause health problems. A new study published in the September 4, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology, examined if thinking and memory skills were associated with cadmium exposure. They found no association when they looked at the group as a whole. However, when looking at Black and white people separately, it found cadmium may be tied to problems with thinking and memory skills in white people. ...

Strictest abortion-ban states offer least family support

Strictest abortion-ban states offer least family support
2024-09-04
View a breakdown of the abortion restrictions by state below States with early abortion bans are less likely to offer paid time off after childbearing, to give poor children nutritional support or to expand access to reproductive health care Marginalized people and those with low socioeconomic status are overrepresented in ban states and least likely to overcome the barriers that bans impose CHICAGO --- States with the most severe post-Dobbs abortion restrictions also have the fewest policies in place to support raising families, reports a new Northwestern Medicine study.  “We found that in the states that most severely ...

Study: People facing life-or-death choice put too much trust in AI

Study: People facing life-or-death choice put too much trust in AI
2024-09-04
In simulated life-or-death decisions, about two-thirds of people in a UC Merced study allowed a robot to change their minds when it disagreed with them -- an alarming display of excessive trust in artificial intelligence, researchers said. Human subjects allowed robots to sway their judgment despite being told the AI machines had limited capabilities and were giving advice that could be wrong. In reality, the advice was random. “As a society, with AI accelerating so quickly, we need to be concerned about the potential for overtrust,” said Professor Colin ...

Leaders of ​‘EV Ready’ Illinois cities recognized in ceremony at Argonne

Leaders of ​‘EV Ready’ Illinois cities recognized in ceremony at Argonne
2024-09-04
City leaders who are working to accommodate more electric vehicles (EVs) were recognized in a ceremony o Aug. 23 at the U.S. Department of Energy’s (DOE) Argonne National Laboratory. Utility ComEd and the Metropolitan Mayors Caucus spotlighted 12 communities in northern Illinois that recently completed the EV Readiness Program. The EV Readiness Program trains and assists local government officials in taking concrete steps to support EV adoption. As a national leader in EV research, ...

Survey shows nearly 70% of US hospitals affiliated with medical schools host a fast-food restaurant; Chick-fil-A, McDonald’s among most common

2024-09-04
WASHINGTON, D.C.—A new survey by the Physicians Committee for Responsible Medicine published in the American Journal of Lifestyle Medicine reveals that 69.2% of U.S. hospitals affiliated with a medical school host at least one fast-food restaurant. The five most common fast-food restaurants located in hospitals were Starbucks, Subway, Chick-fil-A, Au Bon Pain, and McDonald’s. “Making fast food like cheeseburgers and fried chicken available in hospitals is hazardous to the health of patients, visitors, and staff,” says Zeeshan Ali, PhD, the lead author of the paper and a nutrition program specialist with the Physicians Committee. “Hospitals ...

Study solves testosterone’s paradoxical effects in prostate cancer

2024-09-04
DURHAM, N.C. – A treatment paradox has recently come to light in prostate cancer: Blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay disease progression in patients whose disease has advanced.   The inability to understand how different levels of the same hormone can drive different effects in prostate tumors has been an impediment to the development of new therapeutics that exploit this biology.   Now, a Duke Cancer Institute-led study, performed ...

New UMass study shows that ‘super spikes’ can increase track running speed by 2%

New UMass study shows that ‘super spikes’ can increase track running speed by 2%
2024-09-04
New research published in the Journal of Sport and Health Science led by the University of Massachusetts Amherst shows that super spikes, scientifically described as advanced footwear technology (AFT) spikes, can give runners about a 2% edge in middle-distance track races, like the 800- and 1,500-meters. “Track athletes started wearing super spikes about five years ago and they are now commonplace in elite track races,” says Wouter Hoogkamer, assistant professor of kinesiology at UMass Amherst and senior author ...

Department of Energy announces $118 million for Energy Frontier Research Centers

2024-09-04
WASHINGTON, D.C. -Ten Energy Frontier Research Centers (EFRCs) designed to bring together world-class teams of scientists for groundbreaking fundamental research have been funded in nine states by the U.S. Department of Energy (DOE).  Since 2009, EFRCs  have brought together diverse, world-class teams of scientists to perform basic research that accelerates ground-breaking scientific advances underlying energy technologies. The centers develop powerful new tools for characterizing, understanding, modeling, and manipulating matter, while training the next-generation scientific workforce by attracting talented students passionate about energy science. “Fundamental ...

LAST 30 PRESS RELEASES:

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

More scrutiny of domestic fishing fleets at ports could help deter illegal fishing

Scientists transform plastic waste into efficient CO2 capture materials

Discovery of North America’s role in Asia’s monsoons offers new insights into climate change

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies

Researchers discover massive geo-hydrogen source to the west of the Mussau Trench

Even untouched ecosystems are losing insects at alarming rates, new study finds

Adaptive visible-infrared camouflage with wide-range radiation control for extreme ambient temperatures

MD Anderson research highlights for September 5, 2025

Physicists create a new kind of time crystal that humans can actually see

Reminder: Final media invitation for EPSC-DPS2025 and details of media briefings on RAMSES and Juno missions

[Press-News.org] New guideline for Helicobacter pylori includes change to primary treatment recommendation